Pulmonary arterial hypertension in congenital heart disease: Current perspectives and future challenges

Kempny, 2013, Meeting the challenge: the evolving global landscape of adult congenital heart disease, Int J Cardiol, 168, 5182, 10.1016/j.ijcard.2013.07.198 Gatzoulis, 2014, Pulmonary arterial hypertension associated with congenital heart disease: recent advances and future directions, Int J Cardiol, 177, 340, 10.1016/j.ijcard.2014.09.024 Gatzoulis, 2009, Pulmonary arterial hypertension in paediatric and adult patients with congenital heart disease, Eur Respir Rev, 18, 154, 10.1183/09059180.00003309 Ivy, 2013, Pediatric pulmonary hypertension, J Am Coll Cardiol, 62, D117, 10.1016/j.jacc.2013.10.028 Dimopoulos, 2014, Pulmonary hypertension related to congenital heart disease: a call for action, Eur Heart J, 35, 691, 10.1093/eurheartj/eht437 Simonneau, 2013, Updated clinical classification of pulmonary hypertension, J Am Coll Cardiol, 62, D34, 10.1016/j.jacc.2013.10.029 Dimopoulos, 2008, Evaluating operability in adults with congenital heart disease and the role of pretreatment with targeted pulmonary arterial hypertension therapy, Int J Cardiol, 129, 163, 10.1016/j.ijcard.2008.02.004 Dimopoulos, 2008, Pulmonary arterial hypertension in adults with congenital heart disease: distinct differences from other causes of pulmonary arterial hypertension and management implications, Curr Opin Cardiol, 23, 545, 10.1097/HCO.0b013e3283126954 Diller, 2014, Survival prospects of treatment naïve patients with Eisenmenger: a systematic review of the literature and report of own experience, Heart, 100, 1366, 10.1136/heartjnl-2014-305690 Manes, 2014, Current era survival of patients with pulmonary arterial hypertension associated with congenital heart disease: a comparison between clinical subgroups, Eur Heart J, 35, 716, 10.1093/eurheartj/eht072 Dimopoulos, 2010, Improved survival among patients with Eisenmenger syndrome receiving advanced therapy for pulmonary arterial hypertension, Circulation, 12, 20, 10.1161/CIRCULATIONAHA.109.883876 Schuuring, 2013, Treatment of segmental pulmonary artery hypertension in adults with congenital heart disease, Int J Cardiol, 164, 106, 10.1016/j.ijcard.2011.06.084 Galiè, 2016, 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension, Eur Heart J, 37, 67, 10.1093/eurheartj/ehv317 Giannakoulas, 2015, The Gordian knot of thromboembolism in congenital heart disease, Heart, 101, 1523, 10.1136/heartjnl-2015-308045 Giannakoulas, 2010, Exercise training in congenital heart disease: should we follow the heart failure paradigm?, Int J Cardiol, 138, 109, 10.1016/j.ijcard.2009.06.024 Dimopoulos, 2008, Trials and tribulations in adult congenital heart disease, Int J Cardiol, 129, 160, 10.1016/j.ijcard.2008.06.048 Giannakoulas, 2014, Blood biomarkers and their potential role in pulmonary arterial hypertension associated with congenital heart disease. A systematic review, Int J Cardiol, 174, 618, 10.1016/j.ijcard.2014.04.156 Hebert, 2014, Bosentan improves exercise capacity in adolescents and adults after Fontan operation: the TEMPO (Treatment With Endothelin Receptor Antagonist in Fontan Patients, a Randomized, Placebo-Controlled, Double-Blind Study Measuring Peak Oxygen Consumption) study, Circulation, 130, 2021, 10.1161/CIRCULATIONAHA.113.008441 Tousoulis, 2015, The need for more research in Europe, Hellenic J Cardiol, 56, 449 Diller, 2014, Choice and competition between adult congenital heart disease centers: evidence of considerable geographical disparities and association with clinical or academic results, Circ Cardiovasc Qual Outcomes, 7, 285, 10.1161/CIRCOUTCOMES.113.000555 Ntiloudi, 2016, Adult congenital heart disease: a paradigm of epidemiological change, Int J Cardiol, 218, 269, 10.1016/j.ijcard.2016.05.046 Duffels, 2007, Pulmonary arterial hypertension in congenital heart disease: an epidemiologic perspective from a Dutch registry, Int J Cardiol, 120, 198, 10.1016/j.ijcard.2006.09.017